Standard-of-Care Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Also known as: Chemotherapy+T+P, Standard-of-Care medical therapy

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

West German Study Group1
Duk-Woo Park, MD1

Indications

Aortic Valve Stenosis1
Heart Disease1
HER2-positive Early Breast Cancer1
Breast Cancer1
Heart Failure1

Other2 trials

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Phase 4

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.